Skip to content

GudvyoShadi Vati and Shatpushpa Siddha Taila Nasya in the Management of Artavkshaya

A Clinical Study to Evaluate The Combined Effect of GudvyoShadi Vati and Shatpushpa Siddha Taila Pratimarsh Nasya in the Management of Artavkshaya(Hypomenorrhea and Oligomenorrhea) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083115
Enrollment
30
Registered
2025-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

PGIA,JODHPUR,RAJASTHAN,INDIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for the trial Patient between the age After 3 years of menarche to 40 years of age. Oligomenorrhea (delayed menses -Interval of more than 35 days) Hypomenorrhea (scanty menses)- Score less than 10 on PBLAC

Exclusion criteria

Exclusion criteria: Patient less than 3 years of menarche and more than 40 years of age. Lactating women. Patients with any reproductive system abnormalities like hydrosalpinx, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg). Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy. Patients who are contraindicated for Nasya like, Nasal polyp etc.

Design outcomes

Primary

MeasureTime frame
Assessment of SUBJECTIVE PARAMETERS Duration of menstrual bleeding Interval between two cycles Amount of menstrual flow. Pain during menstruation. OBJECTIVE PARAMETERS Serum LH and serum FSH level test Thyroid stimulating hormone test (TSH) Ultrasonography (Pelvis)Timepoint: 28 Days (2 consecutive menstrual cycles)

Secondary

MeasureTime frame
To Assess improvement in SUBJECTIVE PARAMETERS Duration of menstrual bleeding Interval between two cycles Amount of menstrual flow. Pain during menstruation. OBJECTIVE PARAMETERS Serum LH & serum FSH level test Thyroid stimulating hormone test (TSH) Ultrasonography (Pelvis)Timepoint: 28 Days (2 consecutive menstrual cycles)

Countries

India

Contacts

Public ContactDr Bhumika Sharma

PGIA,JODHPUR

dr.ashakp07@gmail.com9995917339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026